Latest filing published 30 Nov 2021 for Eastwood Bio-Medical Canada Inc., €209.
Youngsoo Kim discloses dealings in Eastwood Bio-Medical Canada Inc. to SEDI. Over a trading history stretching from 2 July 2015 to 30 November 2021, the count stands at 17 filings.
Every open-market trade on record is a purchase: 14 purchases worth €163k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2021 alone, the filings show 11 purchases and no sales.
In size, the median ticket on the buying side is €1,405. The 14 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 30 November 2021, the filings show an open-market purchase worth €101 in Eastwood Bio-Medical Canada Inc. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations